Study #2021-0047
A Phase 1, Multi-Center, Open-Label, Dose Finding Study of CC-96191 in Subjects with Relapsed or Refractory Acute Myeloid Leukemia
MD Anderson Study Status
Not Accepting
Treatment Agent
Description
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Study phase:
Physician name:
Tapan Kadia
Department:
Leukemia
For general questions about clinical trials:
1-833-976-0305
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.